U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12 ...
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
SAN FRANCISCO, February 13, 2025 -- ( BUSINESS WIRE )-- Junevity, a biotechnology company on a mission to extend lifespan and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback